Amanote Research

Amanote Research

    RegisterSign In

Cardiovascular Risk in Idiopathic Pulmonary Fibrosis

International Journal of Pulmonary & Respiratory Sciences
doi 10.19080/ijoprs.2018.03.555623
Full Text
Open PDF
Abstract

Available in full text

Date

September 21, 2018

Authors
Muhunthan Thillai
Publisher

Juniper Publishers


Related search

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

Managing Comorbidities in Idiopathic Pulmonary Fibrosis

International Journal of General Medicine
Medicine
2015English

Cell Therapy in Idiopathic Pulmonary Fibrosis†

Medical Sciences
2018English

Serum Biomarkers in Idiopathic Pulmonary Fibrosis

Pulmonary Pharmacology and Therapeutics
BiochemistryMedicinePulmonaryRespiratory MedicinePharmacology
2010English

Idiopathic Pulmonary Fibrosis in Monozygotic Twins

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1980English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Idiopathic Pulmonary Fibrosis and Pirfenidone

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Focus on Idiopathic Pulmonary Fibrosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy